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INTRODUCTION
Treatment of atrial fibrillation (AF) has made continuous ad-
vancements since the isolation of ectopic foci in pulmonary 
veins (PVs) was introduced.1 Eliminating AF triggers in PVs has 
become a fundamental procedure in patients with AF. How-
ever, as AF lasts longer, atrial remodeling progresses, and non-
PV atrial substrate plays an important role in arrhythmic foci. 
Thus, a strategy to modify left atrial (LA) substrate was intro-
duced by Nademanee who demonstrated the clinical implica-
tions of catheter ablation of complex fractionated atrial elec-
trograms (CFAEs).2 Further, it has been reported that catheter 
ablation of CFAEs with PV isolation (PVI) reduces clinical re-
currence and repeat procedures in patients with persistent AF 
(PeAF).3 We also previously reported an association between 
CFAEs and LA wall thickness (LAWT).4,5 Meanwhile, however, 
the mechanism of CFAEs is still controversial and an addition-
al line ablation for reducing the critical mass of LA substrate 
has not shown any additive effects.6 As a consequence, PVI still 
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plays the most important role in preventing AF progression and 
reconnection of PV potentials (PVPs). 
A perfect PVI is affected by anatomical variations in the PVs, 
exact catheter contact, and whether or not there is an adequate 
energy delivery to the endocardium. The development of 3-di-
mensional cardiac computed tomography (3D-cCT) images 
made it possible to confirm the LA structure, anatomy, and 
thickness beforehand. In our previous study, we showed an as-
sociation between change in LA substrate and the presence of 
CFAEs.4,5 Therefore, “tailor-made ablation” according to wall 
thickness may be possible by confirming LA anatomical varia-
tion and antral wall thickness around PVs (PVWT) beforehand, 
potentially improving catheter ablation outcomes. The pur-
pose of this study was to evaluate characteristics of PVWT ac-
cording to underlying disease and to identify associations be-
tween PVWT and reconnections of PVPs in patients undergoing 
redo-ablation.
MATERIALS AND METHODS
Patient selection
The study protocol was approved by the Institutional Review 
Board of Severance Hospital, Yonsei University Health System. 
All patients provided written informed consent. The study in-
cluded 28 non-valvular paroxysmal AF (PAF) patients (22 males, 
mean age 53.6±12.4 years) who underwent a redo-ablation pro-
cedure due to recurrent AF after radiofrequency catheter abla-
tion (RFCA) of drug-refractory AF between January 2009 and 
December 2012. All patients maintained an optimal anticoag-
ulation (target INR 2.0–3.0) before the procedure, and all anti-
arrhythmic drugs were discontinued for at least five half-lives 
of each drug and for at least 4 weeks, especially amiodarone. 
We examined all patients with transthoracic echocardiography 
(TTE) and 3D-cCT before the first ablation for AF in order to 
measure the PVWT and to define LA anatomy before the 
RFCA.
Cardiac CT and image acquisition4,5 
All patients underwent 3D-cCT before RFCA of PAF. All con-
trast-enhanced 3D-cCT examinations were performed using 
a second generation dual-source CT scanner (Somatom Defi-
nition Flash, Siemens Healthcare, Forchheim, Germany). A 
contrast agent (Iopamiro 370; 370 mg iodine/mL, Bracco, Mi-
lan, Italy) was injected using a power injector (Envision CT, Me-
drad, Warrendale, PA, USA) at a flow rate of 5 mL/s into the right 
antecubital vein with the triple phase injection method. Follow-
ing the administration of 60–80 mL of a contrast agent, 30 mL of 
a 70:30 saline-to-contrast mixture and 20 mL of pure saline 
were administered at a flow rate of 5 mL/s through the same 
venous access. Scanning was performed with the following pa-
rameters: prospective electrocardiography (ECG)-gated axial 
acquisition targeting the end-systolic phase using the absolute 
delay method, detector configuration of 2×64×0.6 mm (acqui-
sition of 2×128 sections per rotation using a z-axis flying focal 
spot), gantry rotation time of 0.285 s, tube potential of 80–120 
kVp, and tube current-time product of 280–450 mAs, depend-
ing on the patient’s body mass index. The scan delay time was 
determined by the test-bolus technique for optimal contrast 
enhancement. After injection of a 10-mL bolus of iopamiro, the 
optimal delay times were determined by automatic detection 
of contrast enhancement in the ascending aorta. Reconstructed 
images were transferred to an image server and analyzed using 
commercially available 3D software (Aquarius iNtuition, Ver 
4.4.6, TeraRecon, San Mateo, CA, USA). 
Measurements of the LA antral wall thickness around 
the PVs (PVWT)
A radiologist blinded to the patients’ clinical and electrophysi-
ological information evaluated the CT images independently. 
The intra- and inter-observer correlation thereof was already 
confirmed in a previous study.4,5 For the measurement of the 
PVWTs, all CT images were transferred to commercially avail-
able 3D reconstruction software (Aquarius iNtuition, Ver 4.4.6, 
TeraRecon), and then multiplanar (MPR) images were recon-
structed. Using axial and coronal images, oblique axial images 
and oblique coronal images were obtained, which were paral-
lel to the target PV passage. Then, a true enface view of the 
target PV was obtained, which was simultaneously perpen-
dicular to the previous oblique axial and oblique coronal im-
ages. The lung parenchyma and fat tissue were automatically 
masked from the PVs using an auto-segmentation technique 
with a default range from -1024 to -45 Hounsfield unit (HU). 
On the enface view, the PVWTs were measured carefully at 12 
equiangular points (1 o’clock to 12 o’clock sites) using electrical 
calipers. The PVWT was measured with the Aquarius iNtuition 
software. First, the oblique axial images (Fig. 1A) and oblique 
coronal images (Fig. 1B) were obtained, which were parallel 
to the target PV passage (right superior PV) using axial and 
coronal images (not shown here). Then, a true enface view of 
the target PV (Fig. 1C) was obtained, which was simultaneous-
ly perpendicular to the previous oblique axial (Fig. 1A) and 
oblique coronal (Fig. 1B) images. The lung parenchyma and 
fat tissue were automatically masked from the target PV using 
an auto-segmentation technique with a default range from 
-1024 to -45 HU (blue area). On the enface view, the PVWTs 
were measured carefully at 12 equiangular points (1 o’clock to 
12 o’clock sites) using electrical calipers (Fig. 1D). The LA an-
trum around the PVs (PVW) was defined as the region consist-
ing of a 10-mm space between the PV ostium and left atrium.
Study protocol and assessing the presence of 
reconnected PV potentials during the redo-ablation 
All patients underwent circumferential PVI (CPVI) and cavo-
tricuspid isthmus block without an additional line or CFAE abla-
tion in the first ablation for PAF. An open irrigated tip, 3.5-mm-
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tip deflectable catheter (Thermocool, Johnson & Johnson Inc., 
Diamond Bar, CA, USA; Coolflex, St. Jude Medical Inc., Min-
netonka, MN, USA) was used for the RFCA (Stockert genera-
tor, Biosense Webster Inc.; Diamond Bar, CA, USA; Irvine Bio-
medical, Inc., -1500T11 generator, St. Jude Medical Company, 
CA, USA). All patients were followed-up in the outpatient clin-
ic without the use of any antiarrhythmic drugs after the RFCA. 
The patients visited an outpatient clinic regularly at 1, 3, 6, and 
12 months and then every 6 months or whenever symptoms 
occurred after the RFCA. All patients underwent an ECG at ev-
ery visit and a 24- or 48-hour Holter recording and/or event 
recording at 3, 6, and every 6 months, following the 2012 HRS/
EHRA/ECAS Expert Consensus Statement guidelines. Howev-
er, whenever patients reported palpitations, Holter monitor or 
event monitor recordings were obtained and evaluated for 
possible recurrences of arrhythmias. We defined a recurrence 
of AF as any episode of AF or atrial tachycardia lasting at least 
30 sec.7 Any ECG documentation of AF recurrences after 3 
months was diagnosed as a clinical recurrence,7 and we per-
formed a redo-ablation for the patients who had a clinical re-
currence of AF. At the time of the redo-ablation procedure, we 
first evaluated the presence of reconnected PVPs with a vari-
able loop circular mapping catheter (LASSO®, Biosense Web-
ster Inc., Diamond Bar, CA, USA) of each PV. The sites of re-
connected potentials were marked in a clockwise rotation 
from 1 to 12 (Figs. 1D and 5), and we generated 3D-cCT VR 
images with an electroanatomical mapping system (Ensite 
NavX system, St. Jude Medical Inc., Minneapolis, MN, USA) for 
exact matching with the 3D-cCT and PVP site. 
Echocardiography
All patients underwent TTE (Sonos 5500, Philips Medical Sys-
tem, Andover, MA, USA or Vivid 7, GE Vingmed Ultrasound, 
Horten, Norway) prior to the RFCA. The chamber size (LA vol-
ume index, LA dimension, LV wall thickness, and LV mass in-
dex), transmitral flow velocity (E wave, A wave), and tissue 
Doppler images of the mitral annular septal area (peak diastolic 
velocity and peak systolic velocity) were acquired according to 
the American Society of Echocardiography guidelines.8,9 The 
index was calculated as divided by the body surface area. 
Data analysis
Normally-distributed continuous variables are expressed as the 
mean±standard deviation. The statistical significance of com-
parisons was assessed using Student’s t-test, χ2 test, and ANO-
VA test. A receiver operating characteristic (ROC) curve analy-
Fig. 1. Measurement of the PVWT (left atrial antral wall thickness around the right superior pulmonary vein). The details are described in the Methods 
section. (A) oblique axial images, (B) oblique coronary images, (C) true enface view of the target pulmonary vein, (D) the PVWTs are measured carefully 
at 12 equiangular points (1 o’clock to 12 o’clock sites). PVWT, wall thickness around pulmonary veins.
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sis was conducted to evaluate the prognostic value of PVWT 
in relation to reconnections of the PVPs. A p-value<0.05 was 
considered statistically significant.
RESULTS
Baseline characteristics
A total of 28 patients (78.6% male, 53.6±12.4 years) were en-
rolled. Their mean CHA2DS2-VASc score was 1.4±1.3 with a 
mean LA dimension of 39.6±6.5 mm. The mean wall thickness 
of the 112 PVs (4 PVs×28 patients) was 0.64±0.25 mm (range 
0.13–2.57 mm). Left PVs were thicker than the right PVs (0.67± 
0.24 mm vs. 0.61±0.26 mm, p<0.001) and had more reconnected 
PVs (57.1% vs. 50.0%, p=0.009). However, there was no signifi-
cant difference between the superior and inferior PVs (Table 1). 
LA antral wall thickness according to the presence of a 
stroke and CHA2DS2-VASc (age, hypertension, heart 
failure, and diabetes) score
Generally, the PVW was thickest in those in their mid-fifties; 
however, there was no significant difference in the PVWT in 
the age group analysis according to a cut-off value of 65 years 
(p>0.05) (Fig. 2). Male patients had a greater increased PVWT 
than female patients (0.65±0.26 mm vs. 0.58±0.20 mm, p<0.001) 
(Fig. 3A). Patients with heart failure (0.70±0.23 mm vs. 0.63±0.25 
mm, p=0.002) and diabetes (0.67±0.28 mm vs. 0.63±0.24 mm, 
p=0.045) had an increased PVWT, compared to those without 
(Fig. 3B, C, and D). Interestingly, the patients with stroke had a 
significantly decreased PVWT (0.53±0.18 mm vs. 0.65±0.25 
mm, p<0.001), and patients with a high CHA2DS2-VASc score 
Table 1. Baseline Characteristics of the Enrolled Patients
n=28
Male, n (%) 22 (78.6)
Age, yrs 53.6±12.4
Body surface area (m2) 2.0±0.1
Body mass index (kg/m2) 24.8±2.5
CHADS2 score 1.0±1.1
CHA2DS2-VASc score 1.4±1.3
Congestive heart failure, n (%) 3 (10.7)
Hypertension, n (%) 13 (46.4)
Diabetes, n (%) 6 (21.4)
Stroke, n (%) 4 (14.3)
Vascular disease, n (%) 0 (0)
Echocardiography
LA size, mm 39.6±6.5
LA volume index (mL/m2) 30.7±9.0
LV ejection fraction, % 61.6±6.6
E/E’ 9.2±3.6
LA volume (3D-cCT, mL/m2) 77.1±19.2
LA volume except for the LA appendage (3D-cCT, mL/m2) 70.7±16.2
LA, left atrium; 3D-cCT, 3-dimentional computed tomography; LV, left ventri-
cle.
Fig. 2. The distribution of the PVWT according to age. The PVW was thickest in those in their mid-fifties and became thinner with increasing age. PVWT, 
wall thickness around pulmonary veins.
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(≥3) also had a decreased PVWT (0.59±0.26 mm vs. 0.65±0.25 
mm, p=0.005) (Fig. 4). 
LA antral wall thickness and PV reconnections 
In the redo-ablation procedures, reconnected PVPs were de-
tected in 60 (53.6%) of the 112 PVs, and the sites with recon-
nected PVPs were significantly thicker than those without 
(0.83±0.29 mm vs. 0.63±0.25 mm, p<0.001) (Fig. 5). The area 
under curve of the ROC curve for predicting PV reconnections 
was 0.695; moreover, a PVWT of ≥0.6 mm could predict PV re-
Fig. 3. The difference in the PVWT according to the gender (A) and underlying disease, including heart failure (B), hypertension (C), and diabetes (D). 
*p<0.05. PVWT, wall thickness around pulmonary veins.
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to LA volume and dimensions.10-12 Measurement of the volume 
has become more exact with the development of echocardiog-
raphy and 3D-cCT imaging, and even a segmental approach 
for determining the LA volume has recently become possi-
ble.13,14 However, many studies on LA volume by 2D echocar-
diography have shown consistent underestimation, compared 
to 3D-cCT, due to ambiguous endocardial borders and geo-
metric assumption in the apical view. Because 3D-cCT is tomo-
graphic, the chamber orientation and variations of the cardiac 
size and dimension during the cardiac cycle will not affect the 
volume assessments.15 This also allows for fewer geometric as-
sumptions and has the ability to prescribe any plane across the 
LA. LA remodeling in patients with AF progression usually oc-
curs more in the anteroposterior dimension than LA “elonga-
tion”.13 Remodeling of LA dimensions in AF patients might lead 
to underestimation of LA volume. Although this limitation is 
inherent to echocardiography, studies have shown that echo-
cardiography tends to underestimate LA volume and is strongly 
correlated with 3D-cCT measurements.16 These results were 
connections with a sensitivity of 76.7% and specificity of 52.2% 
(Fig. 6).
DISCUSSION
In the present study, males exhibited an increased PVWT, com-
pared to females, and PVW was thickest in those in their mid-
fifties and became thinner with increasing age. Patients with 
heart failure or diabetes had an increased PVWT, compared to 
those without. Meanwhile, patients with stroke or a high 
CHA2DS2-VASc score (≥3) had a lower PVWT than the other pa-
tients. PVWT was associated with advanced LA remodeling re-
lated to underlying disease in patients with PAF and may have 
resulted in the occurrence of a stroke. 
Previous studies related to the LA wall thickness 
and data validation
Many studies have aimed to predict the outcomes of AF related 
Fig. 5. The PVWT and reconnection of the PV potentials (schematic enface view of each PV from 1 to 12 o’clock). The outer circle (blue) indicates the rel-
ative PVWT, and inner circle (orange) the relative ratio of the PV reconnections. The numbers in the parentheses denote the number of PV potentials that 
were detected at each site. RSPV, right superior pulmonary vein; RIPV, right inferior pulmonary vein; LSPV, left superior pulmonary vein; LIPV, left inferior 
pulmonary vein; PVWT, wall thickness around PVs; PV, pulmonary vein.
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similar to our findings. In addition, because the LA wall is very 
thin, its measurement by echocardiography is impossible and 
the development of the 3D-cCT image resolution was neces-
sary for an exact measurement. We already measured the 
LAWT with 31 segmented sites of the LA and showed an asso-
ciation between LAWT and CFAEs.4,5 Further, measurements of 
the LAWT by two independent observers showed an excellent 
agreement (inraclass correlation coefficient=0.984, p<0.001).4,5 
For the measurement of PVWT in this study, the observers de-
termined the points for measurement around the PVs using the 
three-dimensional volume-rendered images and MPR refor-
matted images. If the inner and outer borders of the target wall 
were determined, the PVWT was measured using electronic 
calipers with the same method as the previous study.
Clinical implications of the PVWT
Since CPVI has been an important milestone of the treatment 
of AF,1 its clinical importance has increased even in patients 
with PeAF.6 A complete CPVI and its maintenance is consid-
ered to play an important role in the prevention of AF recur-
rence regardless of AF type. Thus, it is very important to make 
a transmural lesion and complete block around all four PVs af-
ter evaluating the anatomical variation of each PV. However, 
most previous studies have focused on geometric variation 
and exact contact, and there has been no interest regarding the 
proper amount of energy delivery according to wall thickness: 
high energy delivery may be needed for a thick wall, in terms 
of a transmural lesion formation, and a relatively low energy 
delivery could be adequate for a thin wall, considering the risk 
of perforation. Generally, the disappearance of PVPs and an 
increased impedance are considered as endpoints of the abla-
Fig. 6. ROC curve of the PWVT for predicting PV reconnections. ROC, re-
ceiver operating characteristic; PVWT, wall thickness around PVs; PV, 
pulmonary vein.
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tion at each site.17 With this strategy, the information on the 
wall thickness enables a tailored ablation and energy delivery 
at each site. In this study, the reconnection of PVPs was noted 
more frequently at sites with a thick wall after the same abla-
tion strategy, and this finding indicated that tailored ablation 
according to wall thickness may be necessary. Moreover, with 
continuous information, not point-by-point information, on 
the PVWT can be acquired, an exact tailored ablation can be-
come possible and could reduce PV reconnections and the 
risk of ablation.
Another mechanism of strokes: LA remodeling
In this study, males had a thicker wall around PVs than fe-
males, although there was no significant difference according 
to age therein. Further, patients with heart failure or diabetes 
had a thicker wall around the PVs than those without. Heart 
failure with a decreased LV function results in a volume over-
load and pressure increase in the LA, and this change may 
cause an increase in the PVWT and LA wall hypertrophy. Fur-
ther, pathological changes in the myocardium of patients with 
diabetes have already been reported, even though it was with-
out ventricular systolic decompensation. The reported changes 
included myocardia fibrosis,18 deposition of periodic acid-Schiff-
positive material, advanced glycation endproduct deposition,19 
and capillary basement membrane changes.20 As a consequen-
ce, those pathological alterations resulted in an increase in the 
myocardial stiffness, LV mass, and wall thickness.21 Interest-
ingly, we found that patients with stroke or a high CHA2DS2-
VASc score had a thin wall around the PVs. In previous studies, 
patients with PAF exhibited a thicker LA wall than those with 
normal sinus rhythm, although as AF progressed to chronic 
AF, the LA wall became thin.22 The PVWT reflects LA remodel-
ing from AF progression, and as a consequence, a thin PVWT 
may be associated with the occurrence of a stroke due to a high 
CHA2DS2-VASc score, as well as a previous stroke. In the begin-
ning of AF, risk factors, such as heart failure and diabetes, may 
increase the wall thickness around the PVs; however, the PVWT 
will become decreased as the LA remodeling progresses. As a 
result, a thin PVWT may be associated with the occurrence of 
a stroke. Therefore, if measurement of LA PVWT is possible, a 
more exact prediction of a stroke due to AF could potentially 
be accomplished. 
Limitations
This study had some limitations. First, we focused on recon-
nections of the CPVI in patients with PAF and could not ana-
lyze the reconnections and bidirectional block of the linear ab-
lation in those with PeAF, which are related to wall thickness. 
Second, this study had a small number of enrolled patients. 
Third, the reconnection sites of the PVPs during the procedure 
and the PVWT obtained by 3D-cCT could not be simultane-
ously accomplished. Further, measurements around the left 
PVs with the ridge anteriorly are difficult. To overcome this lim-
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itation, we generated cardiac 3D-cCT VR images with an elec-
troanatomical mapping system for an exact matching of the 3D-
cCT and PVP site. Fourth, the PVWTs were measured at just 12 
points around each PV, and continuous measurements should be 
performed in a future study. Finally, we used a low ablation 
power when ablating the posterior wall to avoid any esopha-
geal injury, and could not show any significant correlation be-
tween the PVWT of the anterior and posterior regions accord-
ing to the reconnection sites.
In conclusion, patients with stroke or a high CHA2DS2-VASc 
score had a thinner PVW than those without, and the PVWT 
may be a predictor of a stroke occurrence, as well as previous 
stroke related to LA remodeling due to AF. Further, a thick PVW 
was associated with male patients, diabetes, heart failure, and 
reconnection of PVPs after CPVI.
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